France· FR:68760013
RIFAMYCINE CHIBRET 1 000 000 UI/100 g, pommade ophtalmique
A medicinal product containing rifamycine sodique, registered in France by THEA, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- RIFAMYCINE SODIQUE
- Manufacturer
- THEA
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009309154621 tube(s) aluminium verni de 5 g avec canule polyéthylène haute densité (PEHD)EUR 1.92
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Rifamycine sodique in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- ItalyDOTECINE*12 cpr 200 mg rilascio modificatoMALESCI SpA IST.FARMACOBIOL.
- SpainRIFAMICINA ADALVO 200 MG COMPRIMIDOS DE LIBERACION MODIFICADAAdalvo Competence Center S.R.L.
- FinlandRelafalkAdalvo Competence Center S.R.L.
- PolandRifamycin AdalvoAdalvo Competence Center S.R.L.
- BelgiumRifocine 500 IV 500 mgSanofi Belgium
- SwedenRifamycin Adalvo 200 mg Tablett med modifierad frisättningAdalvo Limited
- GermanyGutiviaLunatus Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Belgium · Rifocine I.V.
- Bulgaria · Relafalk
- Germany · Gutivia
- Finland · Relafalk
- Greece · Relafalk
- Hungary · Relafalk
- Italy · Dotecine, Rifocin
- Luxembourg · Otofa, Rifocine I.V.
- Norway · Relafalk
- Poland · Relafalk
- Portugal · Imfalda, Rifocina
- Sweden · Relafalk
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/87a59b2a-bf63-4e2e-99a1-fb6dcd62552d GET /v1/drugs/87a59b2a-bf63-4e2e-99a1-fb6dcd62552d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68760013",
"date_amm": "1997-12-18",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "RIFAMYCINE SODIQUE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "pommade",
"voies_administration": "ophtalmique",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about rifamycine sodique.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.